‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraise

A rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-known medicine and set its sights on a $50 million fundraise.